The University of Arizona Cancer Center named Emmanuel Katsanis, MD, the program director of the Blood and Marrow Transplantation (BMT) program. This marks the first time that the Cancer Center’s adult and pediatric programs will be under consolidated leadership, which spans the UA Departments of Medicine and Pediatrics, as well as the Sections of Hematology-Oncology and Pediatric Hematology-Oncology.
“My goal is to build and grow our program, both in terms of basic and translational research,” Dr. Katsanis said. “I will put a lot of effort into bringing new ideas here that will eventually become significant advancements in our field.”
As the program director, Dr. Katsanis will guide the integration of the adult and pediatric BMT programs, while maintaining separate clinical services for adult and pediatric patients.
Dr. Katsanis has been a UACC member since 1997. As a physician-scientist, Dr. Katsanis provides clinical care for children with cancer and blood disorders and conducts research at the UA Steele Children's Research Center. He currently serves on National Institute of Health grant study sections, numerous international granting organizations and on journal editorial boards.
“As an established investigator with an interest in the host immune response and transplant biology, Dr. Katsanis is in an ideal position to lead and coordinate the research goals and direction for an integrated BMT Program,” said Michael Bookman, MD, the UACC’s section chief of Hematology-Oncology.
During his time as a pediatric oncologist, Dr. Katsanis has provided care for children with cancer and other blood diseases at Diamond Children’s Medical Center at the University of Arizona Medical Center and the Hematology/Oncology/BMT Clinic, an outpatient clinic housed within UAMC.
In addition to his clinical duties, Katsanis is a professor of Pediatrics, Pathology and Immunobiology and an associate chair for research in the Department of Pediatrics.
He is also the Louise Thomas Chair in Pediatric Cancer Research and the director of the MD-PhD Program for the UA College of Medicine.
“Dr. Katsanis is an outstanding clinician/scientist who has the experience and leadership skills to build a BMT program that will rank among the best in the world,” added Bruce Coull, MD, the associate dean for clinical affairs in the UA College of Medicine.
Dr. Katsanis received his MD from the National University of Athens Medical School in Greece. He did postdoctoral work in medicine and a rotating internship at McGill University, Montreal, Canada, followed by a pediatric residency at the University of Ottawa in Canada. He completed his fellowship in pediatric hematology, oncology and bone marrow transplantation and postdoctoral work in tumor and transplant immunology leading to an assistant professor position in the Department of Pediatrics at the University of Minnesota.
Dr. Katsanis has published extensively in the areas of cancer immunology and hematopoietic stem cell transplantation. He has received grants from the Medical Research Council of Canada, the National Institutes of Health, the Department of Defense, the Canadian and American Cancer Societies and the Leukemia and Lymphoma Society.
March 2, 2012